| 02nd week of 2020 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20200009040 | TOPICAL FORMULATIONS AND METHODS | 2020-01-09 |
| 20200009041 | Polymer Comprising Certain Level Of Bio-Based Carbon | 2020-01-09 |
| 20200009042 | METHOD OF SKIN REJUVENATION USING STEM CELL ENGRAFTMENT | 2020-01-09 |
| 20200009043 | Cosmetic Composition for Keloid Scar Improvement | 2020-01-09 |
| 20200009044 | ARTIFICIAL TEAR, CONTACT LENS AND DRUG VEHICLE COMPOSITIONS AND METHODS OF USE THEREOF | 2020-01-09 |
| 20200009045 | THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE | 2020-01-09 |
| 20200009046 | Food for Improving Intraintestinal Environment | 2020-01-09 |
| 20200009047 | MARIJUANA SPIRIT SPIKER AND METHOD | 2020-01-09 |
| 20200009048 | SUGAR-DEPLETED FRUIT OR VEGETABLE JUICE AND JUICE-RETAINING FRUIT OR VEGETABLE DERIVED MATTER, METHODS OF PRODUCING THE SAME AND THE USE THEREOF TO MAINTAIN HEALTH AND TO TREAT AND PREVENT MEDICAL AILMENTS | 2020-01-09 |
| 20200009049 | GENERATION OF THERAPEUTIC MICROFOAM | 2020-01-09 |
| 20200009050 | PHARMACEUTICAL COMPOSITION, PREPARATION AND USES THEREOF | 2020-01-09 |
| 20200009051 | LIPOSOMAL REHYDRATION SALT FORMULATION AND ASSOCIATED METHODS OF USE | 2020-01-09 |
| 20200009052 | Inverting Device for Liposome Preparation by Centrifugation | 2020-01-09 |
| 20200009053 | MATERIALS AND METHODS FOR DELIVERING COMPOSITIONS TO SELECTED TISSUES | 2020-01-09 |
| 20200009054 | PHYSIOLOGICALLY ACTIVE SUBSTANCE CARRIER | 2020-01-09 |
| 20200009055 | TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION | 2020-01-09 |
| 20200009056 | ORGANIC COMPOUNDS | 2020-01-09 |
| 20200009057 | GATE FOR A TABLET DISCHARGE OF A TABLET PRESS AND METHOD FOR ACTUATING A GATE | 2020-01-09 |
| 20200009058 | GATE FOR A TABLET DISCHARGE OF A TABLET PRESS, AND METHOD FOR ACTUATING A GATE | 2020-01-09 |
| 20200009059 | Multiple Unit Dosage Form Having A Therapeutic Agent In Combination With A Nutritional Supplement | 2020-01-09 |
| 20200009060 | IMPROVED DRUG FORMULATIONS | 2020-01-09 |
| 20200009061 | SOLID PHARMACEUTICAL FORMULATIONS OF ASIMADOLINE | 2020-01-09 |
| 20200009062 | MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF | 2020-01-09 |
| 20200009063 | FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE | 2020-01-09 |
| 20200009064 | ABUSE RESISTANT CAPSULE | 2020-01-09 |
| 20200009065 | STIMULI-RESPONSIVE PARTICLES ENCAPSULATING A GAS AND METHODS OF USE | 2020-01-09 |
| 20200009066 | Warming Composition and Aerosol Formulation Including Same | 2020-01-09 |
| 20200009067 | FORMULATION AND METHOD FOR INCREASING ORAL BIOAVAILABILITY OF DRUGS | 2020-01-09 |
| 20200009068 | NANOPARTICLE FORMULATIONS FOR ENHANCED DRUG DELIVERY TO THE BLADDER | 2020-01-09 |
| 20200009069 | ZWITTERIONIC DENDRITIC AMPHIPHILES, ZWITTERIONIC DENDRIMERS, ZWITTERIONIC TELODENDRIMERS, NANOCARRIERS COMPRISING SAME, AND METHODS OF MAKING AND USING SAME | 2020-01-09 |
| 20200009070 | PROTEASE ASSISTED NATIVE-PROTEIN DELIVERY APPROACH (PANDA) | 2020-01-09 |
| 20200009071 | NEUTRALIZING VENOMOUS BIOMACROMOLECULES | 2020-01-09 |
| 20200009072 | BIOELECTRODE SHEET | 2020-01-09 |
| 20200009073 | Fibre-Free Transdermal Therapeutic System and Method for its Production | 2020-01-09 |
| 20200009074 | SUPPLEMENT PATCH | 2020-01-09 |
| 20200009075 | PATCH BASE AND PATCH USING THE SAME | 2020-01-09 |
| 20200009076 | PHARMACEUTICAL FORMULATIONS OF PHLOROGLUCINOL AND TRIMETHYLPHLOROGLUCINOL | 2020-01-09 |
| 20200009077 | COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES | 2020-01-09 |
| 20200009078 | ORAL COMPOSITIONS | 2020-01-09 |
| 20200009079 | FOODS, SYSTEMS, METHODS, AND KITS FOR PROVIDING ELECTROLYTE REPLACEMENT | 2020-01-09 |
| 20200009080 | TRANSMUCOSAL DELIVERY SYSTEM FOR IDEBENONE | 2020-01-09 |
| 20200009081 | Delivery Of Esketamine For The Treatment Of Depression | 2020-01-09 |
| 20200009082 | ABUSE-PROOFED ORAL DOSAGE FORM | 2020-01-09 |
| 20200009083 | Method of Inhibiting Chronification of Pain | 2020-01-09 |
| 20200009084 | METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS | 2020-01-09 |
| 20200009085 | Methods For Treating Ovarian Cancer | 2020-01-09 |
| 20200009086 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | 2020-01-09 |
| 20200009087 | MULTIPLE MYELOMA TREATMENT | 2020-01-09 |
| 20200009088 | COMPOSITIONS AND METHODS FOR TREATING ANDROGEN-INDEPENDENT CANCER | 2020-01-09 |
| 20200009089 | PHARMACEUTICAL COMPOSITION | 2020-01-09 |
| 20200009090 | NOVEL IMAGING COMPOSITION AND USES THEREOF | 2020-01-09 |
| 20200009091 | RETINOID DERIVATIVES WITH ANTITUMOR ACTIVITY | 2020-01-09 |
| 20200009092 | Treatment of NAFLD and NASH | 2020-01-09 |
| 20200009093 | Sodium Ibuprofen Tablets and Methods of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen | 2020-01-09 |
| 20200009094 | Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases | 2020-01-09 |
| 20200009095 | Ibuprofen for Topical Administration | 2020-01-09 |
| 20200009096 | METHOD FOR TREATING CANCER WITH LOW MOLECULAR WEIGHT COMPONENTS OF AURIN TRICARBOXYLIC ACID COMPLEX | 2020-01-09 |
| 20200009097 | ESTER COMPOUNDS CONTAINING POLYOL AND SACCHARIDE GROUPS EFFECTIVE IN TREATING HEPATOTOXICITY AND USES THEREOF | 2020-01-09 |
| 20200009098 | EFLORNITHINE AND SULINDAC, FIXED DOSE COMBINATION FORMULATION | 2020-01-09 |
| 20200009099 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF SCHISTOSOMIASIS | 2020-01-09 |
| 20200009100 | VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS, ELOVANOID HYDROXYLATED DERIVATIVES, AND METHODS OF USE | 2020-01-09 |
| 20200009101 | PHARMACEUTICAL ACTIVE INGREDIENT AND USE THEREOF, IN PARTICULAR FOR THE PREVENTION AND TREATMENT OF METABOLIC DISORDERS IN HUMANS AND ANIMALS | 2020-01-09 |
| 20200009102 | GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD | 2020-01-09 |
| 20200009103 | CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS | 2020-01-09 |
| 20200009104 | COMBINATION BETWEEN TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE, AN ANTITUMOR PLATINIUM COMPLEX, AND AN IMMUNE CHECKPOINT MODULATOR | 2020-01-09 |
| 20200009105 | PROSTACYCLIN, PROSTACYCLIN ANALOGS, AND METHODS OF TREATING OR PREVENTING REJECTION OF SOLID ORGAN TRANSPLANTS | 2020-01-09 |
| 20200009106 | TREATMENT OF CIRCADIAN RHYTHM DISORDERS | 2020-01-09 |
| 20200009108 | Compositions and Methods for Treating Epithelial Cancer | 2020-01-09 |
| 20200009109 | METHODS OF HEATING CANNABIS PLANT MATERIAL | 2020-01-09 |
| 20200009110 | METHOD FOR TREATING AN ALLERGIC DISEASE | 2020-01-09 |
| 20200009111 | AGENT EXHIBITING ANTI-STRESS, ANXIOLYTIC AND ANTI-DEPRESSION ACTIVITY, AND COMPOSITION BASED THEREON | 2020-01-09 |
| 20200009112 | METHODS AND COMPOSITIONS FOR MODULATING HORMONE LEVELS | 2020-01-09 |
| 20200009113 | USE OF CARBAMATE COMPOUND IN ORDER TO PREVENTATIVELY TREAT HEADACHES | 2020-01-09 |
| 20200009114 | COMPOSITIONS AND METHODS FOR NON-SURGICAL TREATMENT OF PTOSIS | 2020-01-09 |
| 20200009115 | COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES | 2020-01-09 |
| 20200009116 | ADMINISTRATION OF ANTIBIOTIC COMPOUNDS FOR THE TREATMENT OF STREPTOCOCCAL INFECTIONS FOR THE TREATMENT OF PSORIASIS | 2020-01-09 |
| 20200009117 | COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS | 2020-01-09 |
| 20200009118 | COMPOSITIONS AND METHODS FOR THE TREATMENTOF NEURODEGENERATIVE AND OTHER DISEASES | 2020-01-09 |
| 20200009119 | Methods and Compositions to Inhibit Symptoms Associated with Veisalgia | 2020-01-09 |
| 20200009120 | AMINOAMIDE COMPOUNDS | 2020-01-09 |
| 20200009121 | Purpose for Soothing Brain Disorders of Patients from Drug Detoxification Using Biperiden HCL | 2020-01-09 |
| 20200009122 | FORMULATIONS OF PIMAVANSERIN | 2020-01-09 |
| 20200009123 | METHOD OF TREATING A SKIN CONDITION | 2020-01-09 |
| 20200009124 | PHARMACEUTICAL COMPOSITION CONTAINING NICOTINIC ACID AND/OR NICOTINAMIDE AND/OR TRYPTOPHAN FOR POSITIVELY INFLUENCING THE INTESTINAL MICROBIOTA | 2020-01-09 |
| 20200009125 | Pharmaceutical Compositions For Poorly Water-Soluble Compounds | 2020-01-09 |
| 20200009126 | TOBACCO- AND SMOKE-LESS PRODUCTS CONSUMABLE BY HUMANS AS EPICUREAN OR MEDICAL PRODUCTS AND METHOD OF TREATING SMOKING ADDICTION | 2020-01-09 |
| 20200009127 | USE OF MTOR INHIBITOR AND CHLOROQUINE FOR TREATING CANCER | 2020-01-09 |
| 20200009128 | THERAPEUTIC AGENT FOR FIBROSIS | 2020-01-09 |
| 20200009129 | ALKYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS | 2020-01-09 |
| 20200009130 | OCULAR DISTRIBUTION AND PHARMACOKINETICS OF LIFITEGRAST FORMULATIONS | 2020-01-09 |
| 20200009131 | HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | 2020-01-09 |
| 20200009132 | SMALL MOLECULE BAX INHIBITORS AND USES THEREOF | 2020-01-09 |
| 20200009133 | NON-PLATINUM-BASED ANTI-CANCER COMPOUNDS FOR USE IN TARGETED CHEMOTHERAPY | 2020-01-09 |
| 20200009134 | Method and Compound for Modifying Circadian Clock | 2020-01-09 |
| 20200009135 | THERAPEUTIC APPLICATIONS OF MALT1 INHIBITORS | 2020-01-09 |
| 20200009136 | A PHARMACEUTICAL COMPOSITION COMPRISING ROSUVASTATIN AND EZETIMIBE AND A PREPARATION METHOD THEREOF | 2020-01-09 |
| 20200009137 | TOPICAL FORMULATIONS AND USES THEREOF | 2020-01-09 |
| 20200009138 | METHODS AND COMPOSITIONS FOR TREATMENT OF BRAF MUTANT CANCERS | 2020-01-09 |
| 20200009139 | COMPOUNDS USEFUL FOR INHIBITING ROR-GAMMA-T | 2020-01-09 |
| 20200009140 | PYRIDYL DERIVATIVES AS BROMODOMAIN INHIBITORS | 2020-01-09 |
